Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

1.51
Delayed Data
As of 4:15pm ET
 -0.02 / -1.31%
Today’s Change
0.67
Today|||52-Week Range
6.50
-52.57%
Year-to-Date

Today’s Trading

Previous close1.53
Today’s open1.54
Day’s range1.50 - 1.75
Volume9,393,076
Average volume (3 months)2,981,829
Market cap$154.5M
Dividend yield--
Data as of 4:15pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-163.97%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratio1.0
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CURRCure Pharmaceutical ...+0.10+1.52%
RDHLRedhill Biopharma Lt...+0.12+1.34%
OCXOncoCyte Corp+0.05+0.93%
BDSIBioDelivery Sciences...+0.10+3.51%
Data as of 4:01pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$174.8M
Annual profit (last year)$125.7M
Net profit margin71.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael E. Castagna
Chief Financial &
Accounting Officer
Rosabel Realica Alinaya
Corporate headquarters
Valencia, California

Forecasts